Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer

Clinical trial NCT05245682 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05245682
Sponsor: Emory University
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Head and Neck Carcinoma of Unknown Primary Locally Advanced Head and Neck Squamous Cell Carcinoma Locally Advanced Hypopharyngeal Squamous Cell Carcinoma Locally Advanced Laryngeal Squamous Cell Carcinoma Locally Advanced Nasopharyngeal Squamous Cell Carcinoma Locally Advanced Oropharyngeal Squamous Cell Carcinoma

Start date: 2022-02-17
Primary completion: 2024-01-15
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.